In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

E-Prescribing Committee Endorses NCPDP Standard For Rx Transmissions

Executive Summary

The National Council for Prescription Drug Programs SCRIPT standard and its code sets should be used for electronic communication of prescription information between prescribers and pharmacies, the National Committee on Vital and Health Statistics Subcommittee on Standards and Security said

You may also be interested in...



E-Prescribing Fill Status Notification Recommended For HHS Pilot Test

HHS should assess the electronic fill status notification function as part of its electronic prescribing pilot tests, the National Committee on Vital & Health Statistics Standards & Security Subcommittee draft letter to HHS says

E-Prescribing Fill Status Notification Recommended For HHS Pilot Test

HHS should assess the electronic fill status notification function as part of its electronic prescribing pilot tests, the National Committee on Vital & Health Statistics Standards & Security Subcommittee draft letter to HHS says

Electronic Prior Authorization Costs Should Be Measured In Pilot – Cmte.

The cost implications of automated prior authorization should be measured under the HHS pilot program on electronic prescribing, the National Committee on Vital & Health Statistics/Standards & Security Subcommittee said

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044539

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel